Tickwind
TodayOpportunitiesMarketsHotNewsAI Chat
What's new
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/Compare

NVTS vs TXN

NVTS and TXN side by side — valuation & fundamentals (public data).

Key statistics

NVTS vs TXN key statistics
MetricNVTSNavitas Semiconductor CorporationTXNTEXAS INSTRUMENTS INCORPORATED
Market cap—$251.88B
P/E (TTM)—41.9
P/B—13.99
P/S—14.2x
Dividend yield—1.98%
Revenue—$19.45B(TTM)
Revenue growth (YoY)-44.9%13.0%
Net income—$6.05B(TTM)
Earnings growth (YoY)-38.2%4.2%
EPS, diluted—$6.58(TTM)
EBIT margin-234.7%34.1%
ROE-30.7%27.8%
ROIC—18.3%
Piotroski F—6/9
1y total return+48.1%+55.3%

Figures from SEC filings · for reference only · not investment advice

Growth of $10,000: NVTS vs TXN

$10.0K$10.0K$18.7K2021-01-252026-07-31
MetricNVTSTXN
End value$10.0K$18.7K
Total return-0.2%+86.9%
CAGR-0.0%+12.0%
Volatility117.4%33.1%
Sharpe0.440.39
Sortino0.870.58
Max drawdown-92.0%-33.4%

Based on 1386 common trading days, 2021-01-25 → 2026-07-31 · risk-free 3.83% (current short-Treasury, held constant)

A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.

Related comparisons

AVGO vs TXNMRVL vs TXNAAPL vs MSFTGOOGL vs METAAMZN vs GOOGLMSFT vs GOOGL

Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)